Back

Early-life acquisition of Lactobacillaceae protects against experimental cholera

Chapman, C. M. L.; Di Stefano, S.; Kapinos Silva, A.; Rivera-Chavez, F.

2026-07-09 microbiology
10.64898/2026.07.08.737341 bioRxiv
Show abstract

Cholera causes severe diarrheal illness in young children, but the mechanisms underlying age-dependent susceptibility remain unclear. Experimental cholera in neonatal mice recapitulates age-dependent susceptibility: suckling mice are susceptible to Vibrio cholerae colonization and cholera toxin (CT)-dependent disease, whereas adult mice are not readily colonized and do not develop cholera-like disease. Here, we define a developmental window in which susceptibility declines sharply over the first two postnatal weeks. Maternal antibiotic exposure disrupted vertical transmission of maternal microbiota to offspring and altered distal small intestinal microbiota assembly, extending the window of susceptibility to CT-dependent V. cholerae colonization and disease. Pups born to antibiotic-treated dams exhibited reduced Lactobacillaceae and increased Enterobacteriaceae, and reintroduction of an endogenous Lactobacillus isolate restored offspring lactobacilli levels and reestablished resistance to experimental cholera at two weeks of age. Consistent with a direct protective role, increasing lactobacilli in susceptible neonatal mice reduced experimental cholera burden, and cultures of the endogenous Lactobacillus isolate as well as spent culture media acidified the in vitro growth environment and rapidly eliminated recoverable V. cholerae. Together, these findings identify vertical transmission of maternal microbiota to offspring and lactobacilli-associated antagonism as determinants of early-life resistance to cholera.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 13%
14.5%
2
mBio
833 papers in training set
Top 1%
11.4%
3
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 5%
7.6%
4
Cell Host & Microbe
10 papers in training set
Top 0.1%
6.5%
5
eLife
5828 papers in training set
Top 18%
6.5%
6
Nature
645 papers in training set
Top 4%
3.9%
50% of probability mass above
7
Infection and Immunity
120 papers in training set
Top 0.6%
3.9%
8
Cell Reports
1498 papers in training set
Top 13%
3.1%
9
Cell Host & Microbe
116 papers in training set
Top 0.7%
3.1%
10
PLOS Pathogens
820 papers in training set
Top 5%
3.1%
11
Gut Microbes
78 papers in training set
Top 0.6%
2.6%
12
Science
477 papers in training set
Top 3%
2.5%
13
Cell
431 papers in training set
Top 5%
2.3%
14
Nature Microbiology
155 papers in training set
Top 2%
2.0%
15
Immunity
67 papers in training set
Top 0.9%
2.0%
16
Scientific Reports
3612 papers in training set
Top 57%
1.7%
17
Nature Medicine
125 papers in training set
Top 2%
1.6%
18
Science Advances
1243 papers in training set
Top 21%
1.6%
19
Microbiome
154 papers in training set
Top 2%
1.4%
20
Journal of Clinical Investigation
179 papers in training set
Top 4%
1.3%
21
The Journal of Infectious Diseases
202 papers in training set
Top 3%
1.1%
22
Cell Reports Medicine
153 papers in training set
Top 4%
1.1%
23
Science Translational Medicine
127 papers in training set
Top 3%
1.1%
24
The EMBO Journal
309 papers in training set
Top 6%
1.0%
25
The ISME Journal
228 papers in training set
Top 3%
0.8%
26
Mucosal Immunology
47 papers in training set
Top 1.0%
0.8%
27
JCI Insight
277 papers in training set
Top 8%
0.8%
28
PLOS Genetics
862 papers in training set
Top 14%
0.6%
29
Frontiers in Immunology
638 papers in training set
Top 11%
0.6%
30
mSphere
302 papers in training set
Top 8%
0.6%